Literature DB >> 15063350

Liquid chromatographic determination of amodiaquine in human plasma.

Virendra K Dua1, N C Gupta, V P Sharma, S K Subbarao.   

Abstract

A normal-phase high-performance liquid chromatographic method using dichloromethane- methanol-1M perchloric acid (100:10:0.9, v/v/v) at a flow rate of 1.0 ml min(-1) on a LiChrospher Si column with UV (254 nm) detection has been developed for the determination of amodiaquine and its metabolites desethyl amodiaquine and bisdesethyl amodiaquine in plasma. The limit of quantification was 5 ng ml(-1). Mean within-day and day-to-day coefficients of variation (CV) were 4.10 and 6.27% for amodiaquine, 3.43 and 4.80% for desethyl amodiaquine and 3.53 and 5.23% for bisdesethyl amodiaquine, respectively. Mean extraction recovery of amodiaquine, desethyl amodiaquine and bisdesethyl amodiaquine from plasma were 82.48, 74.50 and 69.65%, respectively. Chloroquine and its metabolite desethyl chloroquine, quinine, sulfadoxine and primaquine do not interfere in the detection of amodiaquine, desethyl amodiaquine and bisdesethyl amodiaquine in plasma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063350     DOI: 10.1016/j.jchromb.2004.01.011

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combination in areas of malaria endemicity.

Authors:  Olumuyiwa N Adedeji; Oluseye O Bolaji; Catherine O Falade; Odusoga A Osonuga; Olusegun G Ademowo
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

2.  A pilot study on quality of artesunate and amodiaquine tablets used in the fishing community of Tema, Ghana.

Authors:  Andrews O Affum; Samuel Lowor; Shiloh D Osae; Adomako Dickson; Benjamin A Gyan; Delali Tulasi
Journal:  Malar J       Date:  2013-06-28       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.